Gastric cancer (HER2-positive metastatic) - trastuzumab: public comments on the ACD Gastric cancer (HER2-positive metastatic) - trastuzumab: comments received from the public through the NICE website Gastric cancer (HER2-positive metastatic) - trastuzumab: comments received from the public by letter This page was last updated: 23 September 2010